| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -17,937 | -14,759 |
| Depreciation and amortization | 4,044 | 2,685 |
| Share-based compensation | 9,210 | 5,674 |
| Loss on debt extinguishment | -2,109 | - |
| Loss on disposal of property and equipment | -2 | -2 |
| Amortization of debt issuance costs | 285 | 252 |
| Non-cash operating lease expense | 447 | 382 |
| Change in fair value of warrants | 1,468 | 1,256 |
| Provision for credit losses | 1,485 | 490 |
| Amortization of deferred commissions | 2,467 | 1,561 |
| Accounts receivable | 19,514 | 10,360 |
| Inventory | -148 | 173 |
| Prepaid expenses and other current assets | 1,570 | 870 |
| Deferred commissions | 2,319 | 1,423 |
| Other non-current assets | -181 | -118 |
| Accounts payable | 1,373 | 1,016 |
| Operating lease liabilities | -415 | -415 |
| Accrued expenses and other current liabilities | 7,782 | -4,780 |
| Deferred revenue | 7,627 | 5,995 |
| Other non-current liabilities | 0 | 89 |
| Net cash used in operating activities | -3,127 | -13,260 |
| Purchases of property and equipment | 1,123 | 586 |
| Capitalized internal-use software costs | 3,363 | 1,913 |
| Net cash used in investing activities | -4,486 | -2,499 |
| Proceeds from exercise of stock options | 5,993 | 3,908 |
| Payment of deferred offering costs | 4,284 | 1,927 |
| Repayment of debt principal | 30,963 | - |
| Payment of debt extinguishment costs | 1,430 | - |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 160,532 | 160,532 |
| Net cash provided by (used in) financing activities | 129,848 | 162,513 |
| Net increase (decrease) in cash and cash equivalents | 122,235 | 146,754 |
| Cash and cash equivalents at beginning of period | 76,392 | - |
| Cash and cash equivalents at end of period | 198,627 | - |
Omada Health, Inc. (OMDA)
Omada Health, Inc. (OMDA)